KCM
PFE icon

Karsch Capital Management’s Pfizer PFE Stock Holding History

Karsch Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,557,812
Closed -$41.4M – 35
2013
Q2 		$41.4M Buy
+1,557,812
New +$43M 3.51% 13

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Karsch Capital Management's PFE Position: Q3 2013 in Review

Karsch Capital Management sold out of Pfizer (PFE) in Q3 2013, closing a stake of 1,557,812 shares — an estimated $41.4M sold.

Karsch Capital Management first reported a position in PFE in Q2 2013 and held it in 1 quarter. The position peaked at $41.4M in Q2 2013. 1,605 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

  • Karsch Capital Management reported no remaining Pfizer position as of Q3 2013 after selling out during the quarter.
  • Karsch Capital Management sold 1,557,812 Pfizer shares in Q3 2013, an estimated $41.4M.
  • Karsch Capital Management first reported a position in Pfizer in Q2 2013 and held it in 1 quarter.
  • Karsch Capital Management's Pfizer position peaked at $41.4M in Q2 2013.
  • 1,605 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Karsch Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.